Closure beyond clozapine: successfully averting rebound symptoms in a patient with schizoaffective disorder and agranulocytosis

SUMMARY: ‘Rebound’ or ‘withdrawal’ symptoms are frequently observed after a sudden discontinuation of clozapine. We describe a patient with treatment-resistant schizoaffective disorder who developed agranulocytosis on clozapine but was successfully switched to treatment with olanzapine with no deter...

Descripción completa

Detalles Bibliográficos
Autores principales: Green, Alastair, Stephenson, Thomas, Whiskey, Eromona, Shergill, Sukhi S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2019
Materias:
Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537554/
https://www.ncbi.nlm.nih.gov/pubmed/31530315
http://dx.doi.org/10.1192/bjo.2019.31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537554/
https://www.ncbi.nlm.nih.gov/pubmed/31530315
http://dx.doi.org/10.1192/bjo.2019.31

Ejemplares similares